Literature DB >> 29331166

Institution-wide and Within-Patient Evolution of Daptomycin Susceptibility in Vancomycin-Resistant Enterococcus faecium Bloodstream Infections.

Robert J Woods1, Twisha S Patel2, Jerod L Nagel2, Duane W Newton3, Andrew F Read4.   

Abstract

We report daptomycin minimum inhibitory concentrations (MICs) for vancomycin-resistant Enterococcus faecium isolated from bloodstream infections over a 4-year period. The daptomycin MIC increased over time hospital-wide for initial isolates and increased over time within patients, culminating in 40% of patients having daptomycin-nonsusceptible isolates in the final year of the study. Infect Control Hosp Epidemiol 2018;39:226-228.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29331166      PMCID： PMC5854150          DOI： 10.1017/ice.2017.279

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  10 in total

1.  The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions.

Authors:  M Lipsitch; C T Bergstrom; B R Levin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

2.  Correlation between mutations in liaFSR of Enterococcus faecium and MIC of daptomycin: revisiting daptomycin breakpoints.

Authors:  Jose M Munita; Diana Panesso; Lorena Diaz; Truc T Tran; Jinnethe Reyes; Audrey Wanger; Barbara E Murray; Cesar A Arias
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

3.  Epidemiology of vancomycin-resistant enterococci with reduced susceptibility to daptomycin.

Authors:  Theresa Judge; Jason M Pogue; Dror Marchaim; Kevin Ho; Srinivasa Kamatam; Shakila Parveen; Namita Tiwari; Priyanka Nanjireddy; Suchitha Bheemreddy; Caitlin Biedron; Sagar Mallikethi Lepakshi Reddy; Vijaykumar Khammam; Indu K Chalana; Rajachendra Shekher Tumma; Vicki Collins; Adnan Yousuf; Paul R Lephart; Emily T Martin; Michael J Rybak; Keith S Kaye; Kayoko Hayakawa
Journal:  Infect Control Hosp Epidemiol       Date:  2012-10-25       Impact factor: 3.254

4.  Emergence of daptomycin-resistant VRE: experience of a single institution.

Authors:  Mini Kamboj; Nina Cohen; Kathleen Gilhuley; N Esther Babady; Susan K Seo; Kent A Sepkowitz
Journal:  Infect Control Hosp Epidemiol       Date:  2011-04       Impact factor: 3.254

Review 5.  Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens.

Authors:  Eric G Pamer
Journal:  Science       Date:  2016-04-29       Impact factor: 47.728

6.  Identification of a novel clone, ST736, among Enterococcus faecium clinical isolates and its association with daptomycin nonsusceptibility.

Authors:  Guiqing Wang; Sitharthan Kamalakaran; Abhay Dhand; Weihua Huang; Caroline Ojaimi; Jian Zhuge; Leslie Lee Yee; Pramod Mayigowda; Pavan Kumar Makam Surendraiah; Nevenka Dimitrova; John T Fallon
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

7.  Emergence of daptomycin non-susceptibility in colonizing vancomycin-resistant Enterococcus faecium isolates during daptomycin therapy.

Authors:  Heinrich Lellek; Gefion C Franke; Carolin Ruckert; Manuel Wolters; Christiane Wolschke; Martin Christner; Henning Büttner; Malik Alawi; Nicolaus Kröger; Holger Rohde
Journal:  Int J Med Microbiol       Date:  2015-09-12       Impact factor: 3.473

8.  Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint?

Authors:  Bhavarth S Shukla; Samuel Shelburne; Katherine Reyes; Mini Kamboj; Jessica D Lewis; Sandra L Rincon; Jinnethe Reyes; Lina P Carvajal; Diana Panesso; Costi D Sifri; Marcus J Zervos; Eric G Pamer; Truc T Tran; Javier Adachi; Jose M Munita; Rodrigo Hasbun; Cesar A Arias
Journal:  Clin Infect Dis       Date:  2016-04-03       Impact factor: 9.079

9.  Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus.

Authors:  Jeremy C Storm; Daniel J Diekema; Jennifer S Kroeger; Sarah J Johnson; Birgir Johannsson
Journal:  Antimicrob Resist Infect Control       Date:  2012-05-29       Impact factor: 4.887

10.  Does High-Dose Antimicrobial Chemotherapy Prevent the Evolution of Resistance?

Authors:  Troy Day; Andrew F Read
Journal:  PLoS Comput Biol       Date:  2016-01-28       Impact factor: 4.475
  10 in total
  4 in total

1.  Impact of an Antimicrobial Stewardship Intervention on Within- and Between-Patient Daptomycin Resistance Evolution in Vancomycin-Resistant Enterococcus faecium.

Authors:  Clare L Kinnear; Twisha S Patel; Carol L Young; Vincent Marshall; Duane W Newton; Andrew F Read; Robert J Woods
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

2.  Daptomycin treatment impacts resistance in off-target populations of vancomycin-resistant Enterococcus faecium.

Authors:  Clare L Kinnear; Elsa Hansen; Valerie J Morley; Kevin C Tracy; Meghan Forstchen; Andrew F Read; Robert J Woods
Journal:  PLoS Biol       Date:  2020-12-17       Impact factor: 8.029

3.  An adjunctive therapy administered with an antibiotic prevents enrichment of antibiotic-resistant clones of a colonizing opportunistic pathogen.

Authors:  Valerie J Morley; Clare L Kinnear; Derek G Sim; Samantha N Olson; Lindsey M Jackson; Elsa Hansen; Grace A Usher; Scott A Showalter; Manjunath P Pai; Robert J Woods; Andrew F Read
Journal:  Elife       Date:  2020-12-01       Impact factor: 8.140

4.  Daptomycin-Resistant Enterococcus Bacteremia Is Associated With Prior Daptomycin Use and Increased Mortality After Liver Transplantation.

Authors:  Rachael A Lee; Jason Goldman; Ghady Haidar; Jessica Lewis; Sana Arif; Jonathan Hand; Ricardo M La Hoz; Stephanie Pouch; Eric Holaday; Heather Clauss; Keith S Kaye; Anoma Nellore
Journal:  Open Forum Infect Dis       Date:  2022-01-22       Impact factor: 3.835
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.